Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest acetylcysteine Stories

2014-03-07 16:22:47

NASHVILLE, Tenn., March 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the efficacy and safety of Caldolor(®) (ibuprofen) Injection will be presented at the Pediatric Anesthesiology 2014 conference in Fort Lauderdale, Florida. The pediatric study met its primary endpoint demonstrating that Caldolor was associated with a statistically significant reduction in temperature within the first 2 hours of...

2014-03-03 08:31:51

NASHVILLE, Tenn., March 3, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol(®) from Astellas Pharma US, Inc. Vaprisol(®) is a patented, prescription brand indicated to raise serum sodium levels in hospitalized patients with hyponatremia. The product was developed and registered by Astellas and was commercially launched in 2006. It is one of two branded prescription products indicated for the treatment of hyponatremia....

2014-02-27 16:27:17

NASHVILLE, Tenn., Feb. 27, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release 2013 year-end financial results after the market closes on Tuesday, March 4, 2014. A conference call and live Internet webcast will be held on Tuesday, March 4, 2014, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the...

2014-02-14 16:25:50

BEDFORD, Ohio, Feb. 14, 2014 /PRNewswire/ -- Ben Venue Laboratories, Inc. today issued a nationwide voluntary product recall: Acetylcysteine Solution 10%, USP, (Manufactured for Roxane Laboratories, Inc.) 10%, 30 mL per vial - NDC #0054-3025-02 - Lot 2005479 - Exp. Date March 2014 This voluntary recall was initiated on February 14, 2014 after the discovery of a single visible glass particle in a vial within the lot listed above. There have been no complaints or adverse events related to a...

2014-02-11 23:24:03

New research suggests the micronutrient may be able to slow the progression of mesothelioma, but only in certain cell lines. Raleigh, NC (PRWEB) February 11, 2014 A new article published in the American Journal of Pathology and detailed by Surviving Mesothelioma finds that the nutrient selenium may one day have a role to play in the treatment of mesothelioma. Selenium is found in meat, fish, poultry, grains and eggs and is most plentiful in Brazil nuts and organ meats. It is essential for...

2014-01-29 12:27:38

OKLAHOMA CITY, Jan. 29, 2014 /PRNewswire/ -- Altheus Therapeutics, Inc. announced the USPTO has allowed patent 8,629,127 B2 covering the oral pharmaceutical composition 5-ASA (5-aminosalicylic acid) and NAC (N-acetylcysteine). Combination therapy patents are uncommon and under-appreciated in the pharmaceutical industry because the Patent Office requires surprising, unexpected, or synergistic benefits from combining active ingredients into a single formulation. Altheus' success in...

2013-10-29 16:26:08

NASHVILLE, Tenn., Oct. 29, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release its third quarter 2013 results after the market closes on Tuesday, November 5, 2013. A conference call and live Internet webcast will be held on Tuesday, November 5, 2013, at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of...

2013-10-23 23:04:13

Researchers continue to link BPA and phthalate exposure to health issues, including infertility. Fairhaven Health’s FertileDetox helps rid the body of harmful environmental toxins to help improve overall reproductive health prior to trying to conceive. Bellingham, Washington (PRWEB) October 23, 2013 Last week researchers convened at the annual American Society of Reproductive Medicine conference in Boston to discuss the link between BPA exposure and fertility issues. The chemical...

2013-10-10 16:27:16

NASHVILLE, Tenn., Oct. 10, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq:CPIX) today announced that data from three recent studies evaluating the safety and efficacy of Caldolor(®) (ibuprofen) Injection will be presented at the Annual Meeting of the American Society of Anesthesiologist in San Francisco. Poster presentations will be presented by Dr. Alberto Uribe, Post Doctoral Researcher, Department of Anesthesiology, Wexner Medical Center at The Ohio State...

2013-10-07 13:47:34

This press release is in support of a presentation by Professor Michael Berk on Monday Oct. 7 at the 26th ECNP Congress in Barcelona, Spain Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression,...